LONDON (Reuters) - GlaxoSmithKline's drug Tykerb failed to hit its goal in a clinical trial testing its role in women with early breast cancer, dimming hopes for its use in this setting.
Source: http://uk.reuters.com/article/2011/12/09/uk-glaxosmithkline-tykerb-idUKTRE7B80J420111209?feedType=RSS&feedName=domesticNews
current affairs beauty computers technology
No comments:
Post a Comment